Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025

Core Insights - Investview, Inc. reported its financial results for Q3 2025, highlighting operational progress and strategic initiatives across its diversified business units [1] Financial Performance - Gross Revenue decreased by 24.3% to $9.5 million for Q3 2025 compared to $12.6 million in Q3 2024 [5] - Net Revenue fell by 22.9% to $9.1 million for Q3 2025 from $11.7 million in the same period last year [5] - For the nine months ended September 30, 2025, Gross Revenue decreased by 28.7% to $30.6 million from $42.9 million in the prior year [5] - Net Revenue for the nine months decreased by 28.2% to $29.1 million from $40.5 million in the comparable prior year period [5] - The company reported a net loss from operations of $1.0 million for Q3 2025, compared to a net loss of $0.7 million in Q3 2024 [5] Cash Flow and Balance Sheet - Cash and cash equivalents decreased by 32.9% to $15.1 million as of September 30, 2025, down from $22.5 million at the end of 2024 [4] - Net cash used in operating activities was $3.1 million for the nine months ended September 30, 2025, compared to net cash provided of $13.0 million in the prior year [5] - Total assets decreased by 12.9% to $27.5 million, while total liabilities decreased by 24.6% to $10.8 million [12] Share Repurchase Program - The company has repurchased over 10.2 million shares at an average price of $0.0179 per share, representing a 40.3% discount to the market value [6] - The total number of common shares outstanding has been reduced by 0.55% to 1,848,994,024 shares as of November 7, 2025 [6] Business Segments Performance - The Financial Education and Technology Segment reported net revenue of $7.1 million for Q3 2025, down from $11.2 million in Q3 2024, attributed to a decrease in membership [7] - The Blockchain Technology and Crypto Mining Segment, SAFETek, reported net revenue of $0.92 million in Q3 2025, an increase from $0.57 million in Q3 2024, driven by rising Bitcoin prices [8] - Renu Laboratories, focusing on health and wellness products, reported $1.1 million in net revenue for Q3 2025, with ongoing investments improving production efficiency [14] Strategic Initiatives - The company is set to launch the myLife Wellness division, expanding its health and wellness product offerings, with a commercial launch planned for Q4 2025 [17] - The Opencash app, a mobile trading platform, is on track for launch in Q4 2025, aimed at providing low-cost, commission-free trading [19][20] - A recent investment of $1.25 million in an early-stage nuclear energy enterprise aligns with the company's long-term growth strategy in emerging sectors [24]